Rodrigo Azambuja
Country Lead
Brazil
Rodrigo Azambuja has 26 years of experience with rare diseases in Brazil.
He previously lead the “Casa dos Raros”* with Professor Giugliani and Antoine Daher first Latin American project, which offers multidisciplinary patient care, education for healthcare professionals, and clinical trials services exclusively for rare diseases.
He also worked at Genzyme, the first biotech company to obtain reimbursement for rare diseases in Brazil. He established institutional relationships in the healthcare ecosystem, including with patient groups and Key Opinion Leaders.
Rodrigo Azambuja
Country Lead
Brazil
Rodrigo Azambuja has 26 years of experience with rare diseases in Brazil.
He previously lead the “Casa dos Raros”* with Professor Giugliani and Antoine Daher first Latin American project, which offers multidisciplinary patient care, education for healthcare professionals, and clinical trials services exclusively for rare diseases.
He also worked at Genzyme, the first biotech company to obtain reimbursement for rare diseases in Brazil. He established institutional relationships in the healthcare ecosystem, including with patient groups and Key Opinion Leaders.
